- Home
- Software Solutions
- Resources
- Corporate
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 45 | |
Additional information about NCT00586092.